News
New physics2market projects funded
The physics2market fund has awarded 10 to 35k euros to five astonishing projects. The projects cover gas sensing in stables, a laboratory facility, SMIs, COVID-19 virus and 3D-printing. The physics2market fund will enabling researchers to make a first step in collaborating with an industrial partner. Gas sensing in stables Marcel van der Horst (HvA) has […]
News
Stairway to Impact Award and Rabo Sustainable Innovation Award for Chris Slootweg & SusPhos
Chemist Chris Slootweg of the University of Amsterdam receives the very first Stairway to Impact Award from Dutch funding agency NWO. Slootweg developed a process to recover phosphate from waste streams, such as sewage, and upcycle it so it becomes suitable for high-end industrial applications. SusPhos has only been around since 2019, but the start-up […]
News
PacingCure wins the Venture Challenge 2020
Amsterdam UMC spin-off PacingCure is the winner of the Venture Challenge at the online edition of the Dutch Life Science Conference on the 26th of November. PacingCure develops precision gene therapies for common cardiac arrhythmias and cardiomyopathies, aiming to restore the natural pacing of the heart. The company is founded on combined research from the […]
News
Startup Digi.bio one of the Top 10 most groundbreaking academic startups in NL
The ten winners of the prestigious Academic Startup Competition 2020 can use the title ‘Best Academic Startup of 2020’ for the coming year. The winning startups were chosen by an expert jury after a thrilling final in which all 20 finalists were asked to pitch. The ten winners were chosen on the basis of their value proposition, the […]
News
Mona Keijzer officially launched ACE initiative MKB Digital Workspace
On Friday November 20 State Secretary Mona Keijzer launched the national SME workshops digitization. The State Secretary for Economic Affairs and Climate talked to SME entrepreneurs and students. During the online event, Mona Keijzer launched the SME workshops by offering them to MKB Nederland. The majority of SME entrepreneurs are aware of the opportunities and […]
News
LUMICKS and Leucid Bio enter into a strategic collaboration
LUMICKS, a spin-off of Vrije Universiteit Amsterdam, is pleased to announce a collaboration agreement with clinical-stage biotech company Leucid Bio, which seeks to utilize LUMICKS’ z-Movi® Cell Avidity Analyzer (z-Movi) to accelerate entry of immunotherapeutic candidates into clinical trials. The goal of the partnership is to evaluate the efficacy of Leucid Bio’s next-generation chimeric antigen […]
News
AVS start-ups continue to develop despite COVID-19
Start-ups and spin-offs affiliated to the Amsterdam Venture Studios establish new partnerships, keep developing and adjusting their innovative products and continue to take the stage in events, despite the disruptive changes the COVID-19 pandemic made in the entrepreneurial ecosystem. Partnerships Establishing new partnerships is important for start-ups. Through partnerships, start-ups can develop their market strategy […]
News
Spreken ze Nederlands in New Jersey en komt robot uit het Tsjechisch?
Tot in de twintigste eeuw werd er Nederlands in de staat New Jersey gesproken, het woord robot is afkomstig uit het Tsjechisch, klanken kunnen hoekig zijn en gedichten kun je ‘schrijven’ in gebarentaal. Deze en nog meer taalvondsten en -feiten vind je in scheurkalender Meer dan woorden alleen. De kalender is samengesteld door taalkundigen van […]
News
Computerspel test potentiële werknemers op integriteit
Integriteit is een persoonlijkheidstrek die relevant is voor hoe mensen zich gedragen, voornamelijk voor mensen in machtsposities. Ondanks dat het mogelijk is met standaard en nieuwe assessmentmethoden – zoals een computerspel – integriteit van potentiele werknemers in kaart te brengen, zijn deze methoden voor het meten van integriteit voor dergelijke openstaande posities zelden onderdeel van […]
News
LAVA therapeutics receives 71 million to advance novel immune oncology programs
Amsterdam UMC spin-off LAVA Therapeutics*, a biotech company pioneering the development of bispecific antibodies to engage gamma-delta T cells for cancer therapies, has raised €71 million to fund the advancement of its pipeline and platform. With the money, LAVA expects to be able to start a number of clinical studies for the treatment of tumors […]
News